169.49
+0.58(+0.34%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1141
First IPO Date
July 19, 2002
| Name | Title | Pay | Year Born |
| Ms. Sandra Saldanha | Whole-Time Executive Non Independent Director | 7.07M | 1971 |
| Mr. Varddhman Vikramaditya Jain | Whole-Time Executive Non Independent Director | 18.75M | 1970 |
| Mr. Mark B. Saldanha | Non-Independent Executive Chairman & MD | 68.86M | 1972 |
| Mr. David Mohammed | Managing Director of Australia Operations | 0 | N/A |
| Mr. Harshavardhan Panigrahi | Company Secretary, Manager of Legal & Compliance Officer | 0 | N/A |
| Mr. Sathish Kumar | Managing Director of UK Operations | 0 | N/A |
| Mr. Anjani Kumar | Chief Operating Officer of US Operations | 0 | 1960 |
| Mr. Vishal Bhargava | Director Operations | 0 | 1970 |
| Mr. Sunil K. Rane | Senior Vice President of QC | 0 | 1969 |
| Mr. Jitendra M. Sharma | Chief Financial Officer | 0 | 1969 |
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.